MRNA

Moderna, Inc (NASDAQ: MRNA) Sec Form 8K

Moderna Inc. (NASDAQ: MRNA) reported fourth-quarter 2025 revenue of $678 million, a 30% decrease from $966 million in the same…

Moderna, Inc (NASDAQ: MRNA) Q4 2025 Earnings Release

Moderna, Inc (NASDAQ: MRNA) Q4 2025 Earnings Conference

Moderna, Inc (NASDAQ: MRNA) Sec Form 8K

Moderna, Inc (NASDAQ: MRNA) FY 2026 Other Release

Moderna, Inc (NASDAQ: MRNA) Q2 2022 Earnings Call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President…

Moderna, Inc (NASDAQ: MRNA) Q2 2025 Earnings Call dated Aug. 01, 2025 Corporate Participants: Lavina Talukdar — Investor Relations Stephane…

Moderna, Inc (NASDAQ: MRNA) Q3 2025 Earnings Call dated Nov. 06, 2025 Corporate Participants: Lavina Talukdar — Head of Investor…

Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company’s revenues declined…